Publications by authors named "Marion Corfmat"
Rheumatology (Oxford)
July 2021
Article Synopsis
- - Systemic inflammatory and autoimmune diseases can occur alongside myelodysplastic syndromes, and current treatments like steroids and biologics are not very effective due to their low response rates and side effects.
- - This study treated three patients with myelodysplastic syndromes and autoimmune disorders using low doses of IL-2, aiming to stimulate regulatory T-cells and reduce reliance on steroids.
- - Results showed clinical improvement and a reduction in steroid use for 2 out of 3 patients, with no serious side effects or disease progression, indicating potential for further research on IL-2 in this context.
